Özet:

Introduction: Liver biopsy is a process made for the diagnosis, evolution of liver diseases, forecast forecast and the decision of the patient’s treatment. Despite the developing methods of imaging today, the serological indicators we use in the diagnosis of liver disease and all other laboratory possibilities, the need for liver biopsy has not decreased, and the reverse quality has increased. In this study in our hospital between January 1998 and June 2007, the indications, complications, and cost of the biopsy of the liver by foot and bed were assessed retrospectively. The findings: 213 (38.5%) patients with foot biopsy were taken to be evaluated with 340 (61.5%) patients with bed biopsy. In patients with footbiopsy, major complications were not observed; in the patient group with bedbiopsy, 6 (1.7%) patients were identified (p<0,05). The factors associated with complications are the experience of the doctor, the number of processes, the use of the tru-cut injection, the extension of the PT value of 4 s and above, the trombocyte value of 80000/mm3 and below, the INR value of 1.2 and above. In both groups, the cost records of 192 patients were accessible. The average cost of the foot-biopsy group was 137±22YTL, while the bed-biopsy group was 214±11YTL (p<0,05). The result: Being-made liver biopsy in experienced hands is as safe as low-bed liver biopsy and the cost is lower. Complications after hepatic biopsy have been found to be associated with the doctor's experience, method, number of processes, hemostasis disorders.

Anahtar Kelimeler: